OrbiMed Israel BioFund GP Limited Partnership 13D and 13G filings for BiomX Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-07-17 8:40 pm Purchase | 2024-07-15 | 13D | BiomX Inc. PHGE | OrbiMed Israel BioFund GP Limited Partnership | 1,787,765 9.990% | 529,983 (+42.14%) | Filing |
| 2024-03-19 9:11 pm Purchase | 2024-03-15 | 13D | BiomX Inc. PHGE | OrbiMed Israel BioFund GP Limited Partnership | 1,257,782 19.900% | 797,601 (+173.32%) | Filing |
| 2024-03-08 4:30 pm Purchase | 2024-03-06 | 13D | BiomX Inc. PHGE | OrbiMed Israel BioFund GP Limited Partnership | 460,181 9.900% | 4,832 (+1.06%) | Filing |
| 2023-05-08 4:43 pm Purchase | 2023-05-04 | 13D | BiomX Inc. PHGE | OrbiMed Israel BioFund GP Limited Partnership | 455,349 9.900% | 101,700 (+28.76%) | Filing |
| 2023-03-17 4:19 pm Purchase | 2023-02-27 | 13D | BiomX Inc. PHGE | OrbiMed Israel BioFund GP Limited Partnership | 353,649 10.500% | 124,600 (+54.40%) | Filing |